Regulatory environment for clinical research: Recent past and expected future
In the past few years, there have been numerous updates to policy and guidelines governing the conduct of clinical research in India. These measures were taken by regulators considering safety of Indian patients as the topmost priority although the overall regulatory environment became challenging....
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Perspectives in Clinical Research |
Subjects: | |
Online Access: | http://www.picronline.org/article.asp?issn=2229-3485;year=2017;volume=8;issue=1;spage=11;epage=16;aulast=Bhave |
id |
doaj-30aa28caba3f4887ba9e8b76331663da |
---|---|
record_format |
Article |
spelling |
doaj-30aa28caba3f4887ba9e8b76331663da2020-11-24T23:40:19ZengWolters Kluwer Medknow PublicationsPerspectives in Clinical Research2229-34852017-01-0181111610.4103/2229-3485.198551Regulatory environment for clinical research: Recent past and expected futureAmita BhaveSuresh MenonIn the past few years, there have been numerous updates to policy and guidelines governing the conduct of clinical research in India. These measures were taken by regulators considering safety of Indian patients as the topmost priority although the overall regulatory environment became challenging. However, in the recent past, Indian regulations have evolved positively to favorably support clinical research in India while appropriately balancing patient safety as well. These regulatory changes are expected to bring newer innovative medicines to Indian patients at an earliest.http://www.picronline.org/article.asp?issn=2229-3485;year=2017;volume=8;issue=1;spage=11;epage=16;aulast=BhaveAmendmentCentral Drugs Standard Control Organizationcirculargazetteguidelinesregulatory environment |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Amita Bhave Suresh Menon |
spellingShingle |
Amita Bhave Suresh Menon Regulatory environment for clinical research: Recent past and expected future Perspectives in Clinical Research Amendment Central Drugs Standard Control Organization circular gazette guidelines regulatory environment |
author_facet |
Amita Bhave Suresh Menon |
author_sort |
Amita Bhave |
title |
Regulatory environment for clinical research: Recent past and expected future |
title_short |
Regulatory environment for clinical research: Recent past and expected future |
title_full |
Regulatory environment for clinical research: Recent past and expected future |
title_fullStr |
Regulatory environment for clinical research: Recent past and expected future |
title_full_unstemmed |
Regulatory environment for clinical research: Recent past and expected future |
title_sort |
regulatory environment for clinical research: recent past and expected future |
publisher |
Wolters Kluwer Medknow Publications |
series |
Perspectives in Clinical Research |
issn |
2229-3485 |
publishDate |
2017-01-01 |
description |
In the past few years, there have been numerous updates to policy and guidelines governing the conduct of clinical research in India. These measures were taken by regulators considering safety of Indian patients as the topmost priority although the overall regulatory environment became challenging. However, in the recent past, Indian regulations have evolved positively to favorably support clinical research in India while appropriately balancing patient safety as well. These regulatory changes are expected to bring newer innovative medicines to Indian patients at an earliest. |
topic |
Amendment Central Drugs Standard Control Organization circular gazette guidelines regulatory environment |
url |
http://www.picronline.org/article.asp?issn=2229-3485;year=2017;volume=8;issue=1;spage=11;epage=16;aulast=Bhave |
work_keys_str_mv |
AT amitabhave regulatoryenvironmentforclinicalresearchrecentpastandexpectedfuture AT sureshmenon regulatoryenvironmentforclinicalresearchrecentpastandexpectedfuture |
_version_ |
1725510055444348928 |